BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 108731
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108731
Figure 1
Figure 1 Diagrammatic overview of glioma grades and their key features. This figure was created by BioRender.com (Supplementary material).
Figure 2
Figure 2 Diagrammatic representation of the biocompatibility concerns associated with mesoporous silica nanoparticles in brain-targeted therapies for glioma, and potential strategies to mitigate their cytotoxicity, including surface PEGylation, targeting of glioma cells, and incorporation of antioxidants. MSN: Mesoporous silica nanoparticle. This figure was created by BioRender.com (Supplementary material).
Figure 3
Figure 3 Schematic of the internal and external triggers for stimuli-responsive mesoporous silica nanoparticle. This figure was created by BioRender.com (Supplementary material).